The Effect of Emotional Freedom Technique on Parents' Anxiety Level: Newborn Hearing Screening

NCT07421063 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-04-15

No results posted yet for this study

Summary

Newborn hearing screening (NHS) is a standard procedure that often triggers acute anxiety in parents. While Emotional Freedom Technique (EFT) has demonstrated efficacy in reducing psychological distress across various clinical settings, its specific application to parental anxiety during the neonatal screening period remains under-researched. This study addresses this gap by investigating the impact of a targeted EFT intervention on anxiety levels in mothers awaiting their newborns' first hearing tests.

The primary objective is to determine if a brief, 15-minute EFT session reduces maternal anxiety more effectively than a standard waiting period. Participants are randomly assigned to either an intervention group, where they perform a structured acupoint tapping sequence, or a control group that receives no active intervention. Anxiety is assessed using validated scales immediately before and after the 15-minute period to capture acute changes in distress. The researchers hypothesize that applying EFT regarding the procedure will significantly reduce parental anxiety levels compared to the non-intervention group.

Conditions

Interventions

BEHAVIORAL

Emotional Freedom Technique

15-minute guided acupoint tapping session

OTHER

No intervention

15-minute waiting period without active guidance

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Principal Investigators

  • Sümeyra Alan, PhD · Bolu Abant İzzet Baysal Üniversitesi

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2026-07-14
Completion
2026-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07421063 on ClinicalTrials.gov